Posts

Moderna Halts Development of CMV Vaccine After Phase 3 Failure

on

Alector's GSK-partnered dementia drug latozinemab fails in late-stage trial

on

Roche Claims Its SERD Is Most Potent After Positive Breast Cancer Data Presented at ESMO 2025

on

Merck Makes Strong Case for Winrevair in Earlier-Stage Pulmonary Arterial Hypertension (PAH) Patients After Positive Phase 3 HYPERION Results

on

BioNTech and DualityBio Achieve Phase 3 Success with ADC Therapy for HER2-Positive Breast Cancer, Advancing Oncology Pipeline

on

Akeso, Summit's PD-1xVEGF Drug Ivonescimab Shows Strong Progression-Free Survival Benefit in Global Lung Cancer Trial

on

PureTech Spins Out Celea Therapeutics to Advance IPF Drug Candidate

on

Roche and AbbVie Announce Phase 3 Venclexta Trial Fails to Meet Primary Endpoint in High-Risk MDS

on

Insmed's 'Unprecedented' Phase 2 PAH Results Propel Stock and Next-Phase Plans

on

Gilead Bolsters Trodelvy in Triple-Negative Breast Cancer With Practice-Changing Keytruda Combo Win

on

ASCO 2025: Amgen’s Imdelltra Cuts Small Cell Lung Cancer Death Risk by 40% Versus Chemo

on

Amgen Secures Phase 3 Survival Data for Imdelltra in Small-Cell Lung Cancer, Strengthening Its Case for Full FDA Approval

on

Alzheon Investigates Subgroup Data Following Phase 3 Trial of ALZ-801 in Alzheimer's Disease

on

Tempest Seeks Strategic Partners to Launch Phase 3 Liver Cancer Trial Amid Funding Challenges

on

Annexon Advances Guillain-Barré Syndrome Awareness and Introduces Groundbreaking Targeted Therapy

on

Cassava Sciences Discontinues Alzheimer's Program After Simufilam Fails Second Phase 3 Trial

on

Sanofi and Johnson & Johnson's E. coli Vaccine Candidate Fails in Phase 3 Trial

on

Inventiva Slashes Workforce and Pipeline to Focus on MASH Drug Lanifibranor

on

Stoke Therapeutics Announces Global Phase 3 EMPEROR Study Design for Zorevunersen in Dravet Syndrome

on